RoosterBio and Secretome Therapeutics Announce Successful Completion of Large Scale Bioreactor Production for Clinical Stage Cell Therapy Candidate STM-01
In March 2025, RoosterBio initiated a development services program to establish a 50L scale cGMP compatible bioreactor-based process for...
Read disclosure →